-
Study aim
-
Determination of mean score of symptoms and quality of life in the intervention group with triamcinolone before and after intervention
Determination of mean score of symptoms and quality of life in control group before and after intervention
Comparison of mean score of symptoms and quality of life after intervention in two groups
-
Design
-
In this study, 100 patients who have undergone rhinoplasty due to allergic rhinitis who are referred to Khatam-ol-Anbia Hospital will be included in the study after explaining the study conditions and obtaining informed consent. After completing the rhinoplasty, the patients completed the questionnaire before the rhinoplasty, and randomly ( by selecting a card from inside the bag containing 50 A cards and 50 B cards) into two groups receiving triamcinolone and the control group , Will be divided.
-
Settings and conduct
-
In this study, 100 patients who have undergone rhinoplasty due to allergic rhinitis who visit Khatam-ol-Anbia Hospital will be included in the study after explaining the study conditions and obtaining informed consent. After completing the rhinoplasty, the patients completed the questionnaire before the rhinoplasty, and randomly ( by selecting a card from inside the bag containing 50 A cards and 50 B cards) into two groups receiving triamcinolone and the control group . In the recipient group, 20 mg of triamcinolone per day will be injected into each lower nasal concha, and no drug will be used in the control group. Finally, one month after injection, symptoms and quality of life of patients are calculated using the standard questionnaire of symptoms and quality of life in patients with allergic rhinitis and will be recorded in a form of information.
Blind: Due to the fact that the intervention is performed during and after anesthesia, the intervention or non intervention group does not know about the intervention.
-
Participants/Inclusion and exclusion criteria
-
Major entry into the study includes all patients who undergo rhinoplasty as a result of allergic rhinitis. Major exclusion criteria include a history of respiratory infections in the past 1 month, systemic illness, alcohol consumption, pregnancy or lactation, corticosteroid therapy, mental disorder.
-
Intervention groups
-
in intervention group,20 mg of triamcinolone per day will be injected into each lower nasal concha, and no drug will be used in the control group.
-
Main outcome variables
-
Determination of the effect of triamcinolone acetate injection on the lower branches of the nose in improving symptoms and quality of life of patients with allergic rhinitis under rhinoplasty